
United States · Biotechnology
NVIGEN is a nanobiotechnology company revolutionizing the field of multifunctional nanoparticles for biomedical applications.
PrivateFor profit
Set against 5,087 Biotechnology companies in United States. The ring marks the typical peer.
Across all 5.9M companies: larger than 33% of those with a size listed; older than 5% of those with a founding year; website ranked #8,992,792 in the world, about 445 visits a month. 12 people list it on LinkedIn, and 544 follow it.
Nvigen is a nanobiotechnology company revolutionizing the field of multifunctional nanoparticles for biomedical applications. Our proprietary nanoparticle-imaging-delivery (NID™) platform enables the engineering of nanoparticles with optimal size, shape, surface, magnetic and optical properties that can be used in sequencing, biopsy, genomics, diagnostics, gene/cell therapy, and drug delivery. We seek to integrate the versatility of nanoscience and innovation to develop solutions that can empower biomedical… Read all
Nvigen is a nanobiotechnology company revolutionizing the field of multifunctional nanoparticles for biomedical applications. Our proprietary nanoparticle-imaging-delivery (NID™) platform enables the engineering of nanoparticles with optimal size, shape, surface, magnetic and optical properties that can be used in sequencing, biopsy, genomics, diagnostics, gene/cell therapy, and drug delivery. We seek to integrate the versatility of nanoscience and innovation to develop solutions that can empower biomedical research.
BiotechnologyClinical TrialsHealth CareNanotechnologyNanobiotechnologyNanoparticle reagentsDrug delivery nanoparticlesDNA Size SelectioncfDNA extractionCirculating Tumor Cell IsolationCell SeparationT-Cell ActivationProtein CaptureImmunodiagnosticsLiquid BiopsySample PreparationHigh Sensitivity TestingAccurate Testing
One of 5,087 Biotechnology companies in United States, and of 16,882 in the industry worldwide.
What the source datasets report. We have not watched these rounds ourselves.
$1.1M
raised in total across 3 rounds
Last raised Mar 2014, 12 years ago
Who started it and how it trades.
Nvigen filed one raise, $1.1M in all. Filings say how much was sold and to how many investors; they never name the investors.
Everything the source datasets list about Nvigen, field by field. Contact details are held but never shown.
The company8 fields
Where4 fields
Size and reach5 fields
Funding, as listed7 fields
About this record2 fields
5,087 Biotechnology companies in United States, filtered by size, age and reach, ready to export with emails on Pro.